Navigation Links
New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
Date:10/25/2008

- One-year study results showed improved physical function in patients treated with ACTEMRA -

NUTLEY, N.J., Oct. 25 /PRNewswire/ -- One-year data from a two-year Phase III study demonstrated that ACTEMRA(R) (tocilizumab) significantly inhibited the progression of structural joint damage in patients with rheumatoid arthritis (RA). Late-breaking results from the LITHE study will be featured as an oral presentation during the American College of Rheumatology (ACR) Annual Scientific Meeting (October 24-28) in San Francisco. Fourteen additional abstracts, which evaluate ACTEMRA, a novel interleukin-6 (IL-6) receptor inhibitor, in patients with moderately to severely active RA, will also be presented during the meeting.

"The LITHE study demonstrated that treatment with ACTEMRA inhibited structural joint damage, which is a major cause of disability and loss of physical function for RA patients," said Joel Kremer, M.D., investigator in the LITHE study and Director of Research at The Center for Rheumatology in Albany, New York. "It is critical to stop joint damage as quickly as possible to avoid joint deformity and to help patients maintain their quality of life."

In the study, the mean change in the combined Genant-modified Sharp score(1), which assesses progression of both joint erosion and joint space narrowing, was lower among ACTEMRA (8 mg/kg and 4 mg/kg) plus methotrexate-treated patients versus methotrexate plus placebo-treated patients (0.3, 0.3 versus 1.1, respectively; p<0.001). In addition, the study showed that 85 percent and 81 percent of patients treated with ACTEMRA (8 mg/kg or 4 mg/kg, respectively) experienced no progression of either joint erosion or joint space narrowing, as measured by the Genant-modified Sharp score, compared with 67 percent of patients treated with placebo plus methotrexate.

Importantly, data from the LITHE study also showed that patients treated with ACTEMRA (8 mg/kg or 4 mg/kg) plus methotrexate expe
'/>"/>

SOURCE Hoffmann-La Roche Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
2. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
3. Life Recovery Systems Receives NIH Grant to Study Expanded Use of Its ThermoSuit System
4. Mindset Media Study Reveals Which Independent Voters Favor Obama Vs. McCain
5. Landmark Study Demonstrates Potential of Radioimmunotherapy for Treatment of Indolent B-Cell Non-Hodgkins Lymphoma
6. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
7. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
8. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
9. Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques
10. Facet Solutions Announces Completion of 6 Month Follow-Up in US Pilot Study
11. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 31, 2014  Zacks.com announces the list of stocks featured in ... the latest news and events impacting stocks and the financial markets. ... AMGN - Free Report ), Celgene (Nasdaq: CELG ... - Free Report ), Market Vectors Biotech ETF (AMEX: ... ETF (AMEX: XBI - Free Report ). ...
(Date:10/31/2014)... , October 31, 2014 Multigate Medical ... patents of B. Braun Melsungen AG (B. Braun) by selling ... safety IV catheters manufactured by Poly Medicure Ltd (Polymed). The ... proceeding number VID 463 of 2013 can be ... detailed judgment, Multigate was found to have infringed claim 1 ...
(Date:10/31/2014)... Oct. 30, 2014 Electronic prescribing ... transmission of prescription related information between prescriber, ... allows a physician and nurse practitioner to ... medication error occurs during pharmacy operations. E-Prescribing ... It provides complete medical lists, conducts all ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 2The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 4The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 5The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 6The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 7B. Braun Wins Patent Disputes Against Poly Medicure Ltd's Australian Distributor Multigate Medical Devices Pty. Ltd. and Spanish Distributor Dextromédica S. L. 2E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2
... Building Comprehensive HIV/AIDS Care Programs in,Resource-Limited Settings" ... Health,Experts, MEXICO CITY, Aug. 5 ... from the "A Day in the Life ... and others, unveiled today a comprehensive guide ...
... and safety of once-daily TMC278 in ... treatment-naive adults with HIV-1 ... IIb data from Tibotec,Pharmaceuticals Ltd. provides additional information on ... reverse transcriptase inhibitor (NNRTI), as part of HIV,combination therapy ...
Cached Medicine Technology:Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City 2Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City 3Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008 2
(Date:10/31/2014)... Daily Gossip writes in its Xtreme Fat Loss review that ... loss program ever developed. It promises to provide users the ... no wonder after all that this has become the most ... and workout fat loss program was created by Joel Marion, ... the author of this fat loss system, the method can ...
(Date:10/31/2014)... Activz Whole-Food Nutrition is ... line offering natural silver healing support† in liquid supplements, ... silver has been used to support natural healing, and ... the most advanced version available. This latest formula, backed ... that supports the existing healing mechanisms in the human ...
(Date:10/31/2014)... terms of duration of treatment and cost, patients ... accelerated partial breast irradiation (APBI) with proton therapy ... research from The University of Texas MD Anderson ... cost analysis study based on typical patient characteristics, ... charges for eight different types of partial and ...
(Date:10/31/2014)... The Suspension Revolution review published by Daily ... by Dan Long, a suspension training specialist. , ... and life coach. The author of this program claims ... not impossible , The Suspension Revolution review reveals that ... promises efficiency when it comes to burning fat, building ...
(Date:10/31/2014)... New York, NY (PRWEB) October 31, 2014 ... on one of the most remarkable gifts of life ... a platform for matching extraordinary surrogate mothers and donors ... stories about individuals in unforeseen circumstances. , It’s a ... sperm donors, surrogacy agencies, surrogacy lawyers, and fertility clinics ...
Breaking Medicine News(10 mins):Health News:Xtreme Fat Loss Diet Review Reveals How to Transform Your Body in 25 Days 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 4Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 3Health News:Suspension Revolution Review Reveals Dan Long's New Suspension Workout Plan 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 3
... the rage among doctors treating patients with blocked arteries, ... link them with a low, but serious risk of ... research by American scientists in two different studies published ... that many doctors have stretched the limit of their ...
... recalling 1.75 quart cartons of Mayfield Turtle Tracks ice cream ... code of 75243-20120. The recall was initiated because the affected ... No other Mayfield Dairy Farms products are involved in this ... the risk of a serious reaction if they consume this ...
... may be the most promising area of research for ... according to a new review in the International Journal ... confirmed the role of hormone therapy in recurrent ovarian ... review author Dr. Siqing Fu, an assistant professor of ...
... its efforts to prevent the spread of drug-resistant ... the public health sector and providing health care ... Skweyiya said at a media briefing on Tuesday, ... that the country is expanding hospital isolation wards ...
... Ministry of External Affairs, informed the Lok Sabha today that ... passports. ,At first these passports will be ... the end of 2007. Based on the experience gained from this ... the ordinary category by the end of 2008. , ...
... the thought that doctors could be on the payrolls of ... rampant in many developing countries. But things are no difference ... repeated visits by representatives of pharmaceutical firms resulted in prescription ... venerable New York Times wrote, doctors who have close relationships ...
Cached Medicine News:Health News:Studies Reveal Inappropriate Use Of Drug-Coated Stents 2Health News:Studies Reveal Inappropriate Use Of Drug-Coated Stents 3Health News:South Africa Increasing Efforts To Contain Drug-Resistant TB, Minister Says 2Health News:Nexus Between Psychiatrists and Drug Firms Dangerous, Say Critics 2Health News:Nexus Between Psychiatrists and Drug Firms Dangerous, Say Critics 3Health News:Nexus Between Psychiatrists and Drug Firms Dangerous, Say Critics 4
... electronic, motorized rotary microtomes ... applications of paraffin, semi-thin ... specimens in clinical, research, ... instruments display extra-ordinary ergonomic ...
... Leica RM2125 microtome comes in two different ... RM2125 RT. All RM2125 versions are now ... entering the precision micrometer feeding system. The ... trimming function and specimen retraction as additional ...
... Leica SM2500 large scale heavy-duty sectioning system is ... sectioning techniques a real working animal. ,Large ... hard materials such as bone or teeth and ... The wide range of accessories, specially designed for ...
... and industrial applications, the Leica SM2400 is ... applications in all laboratories where paraffin or ... Its sturdy construction lends it qualities that ... of the system, such as a sledge ...
Medicine Products: